leisure time -WSS

leisure time

author：entertainment 2025-10-04 05:37:08 - browse：67745

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： States increasingly look to regulate hospital facility fees

WSS

States increasingly look to regulate hospital facility fees

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Syphilis numbers in the United States reach record heights

Philips to halt sales of sleep apnea machines in U.S.

Researchers separate signal from noise in heart wearable data

focus

leisure time

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Venture capital firm's plans to take over Akron hospital face hurdles

Trump demands the U.S. pay no more for drugs than other countries … again

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Bright Health sells Medicare Advantage business to Molina

Man who had jail sentence commuted by Trump arrested again

The cancer drug shortage isn’t new — and neither are the solutions

Norman Reedus' Daryl Dixon

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

hotspot

Why Medicare shouldn’t cover every FDA

Medicare drug price negotiation legal challenge met with skepticism

How dance can help health care workers heal from trauma

Biogen walks away from Aduhelm, years after polarizing approval

Researchers separate signal from noise in heart wearable data

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

focus

leisure time

knowledge

focus